anteris-clinical-research

Anteris Clinical Research

Anteris Clinical Research, a JV partnership between LCTG and Anteris Limited, was formed in response to a referral from Douglas Pharmaceuticals, who recommended a relationship with LCTG to facilitate the BEDROC phase II trial for patients with treatment-resistant depression. Though established for mental health studies, ACR will host clinical trials for a variety of healthcare specialties.

Dr Caleb Armstrong

Owner, Principal Investigator

Anteris Clinical Research